- Home
- FLGT vs CHPT Comparison
FLGT vs CHPT Comparison
Compare FLGT & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- CHPT
- Stock Information
- Founded
- FLGT 2011
- CHPT 2007
- Country
- FLGT United States
- CHPT United States
- Employees
- FLGT N/A
- CHPT N/A
- Industry
- FLGT Medical Specialities
- CHPT Industrial Specialties
- Sector
- FLGT Health Care
- CHPT Consumer Discretionary
- Exchange
- FLGT Nasdaq
- CHPT Nasdaq
- Market Cap
- FLGT 584.9M
- CHPT 468.9M
- IPO Year
- FLGT 2016
- CHPT N/A
- Fundamental
- Price
- FLGT $20.31
- CHPT $0.72
- Analyst Decision
- FLGT Buy
- CHPT Hold
- Analyst Count
- FLGT 2
- CHPT 10
- Target Price
- FLGT $24.00
- CHPT $1.58
- AVG Volume (30 Days)
- FLGT 393.7K
- CHPT 8.5M
- Earning Date
- FLGT 05-02-2025
- CHPT 06-04-2025
- Dividend Yield
- FLGT N/A
- CHPT N/A
- EPS Growth
- FLGT N/A
- CHPT N/A
- EPS
- FLGT N/A
- CHPT N/A
- Revenue
- FLGT $292,448,000.00
- CHPT $417,083,000.00
- Revenue This Year
- FLGT $11.79
- CHPT $12.03
- Revenue Next Year
- FLGT $10.45
- CHPT $26.85
- P/E Ratio
- FLGT N/A
- CHPT N/A
- Revenue Growth
- FLGT 1.71
- CHPT N/A
- 52 Week Low
- FLGT $14.57
- CHPT $0.51
- 52 Week High
- FLGT $25.11
- CHPT $2.44
- Technical
- Relative Strength Index (RSI)
- FLGT 56.64
- CHPT 62.35
- Support Level
- FLGT $20.03
- CHPT $0.66
- Resistance Level
- FLGT $21.42
- CHPT $0.74
- Average True Range (ATR)
- FLGT 0.82
- CHPT 0.04
- MACD
- FLGT 0.03
- CHPT 0.01
- Stochastic Oscillator
- FLGT 63.06
- CHPT 89.87
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About CHPT ChargePoint Holdings Inc.
ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.